| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 139.108 | 80 |
| GSM780708 | Untreated after 4 days (C2_1) | 152.541 | 81 |
| GSM780709 | Untreated after 4 days (C3_1) | 160.447 | 81 |
| GSM780719 | Untreated after 4 days (C1_2) | 150.89 | 80 |
| GSM780720 | Untreated after 4 days (C2_2) | 119.45 | 78 |
| GSM780721 | Untreated after 4 days (C3_2) | 144.313 | 80 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 159.692 | 81 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 133.851 | 79 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 143.389 | 80 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 150.492 | 80 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 125.612 | 78 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 114.765 | 77 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 157.465 | 81 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 198.593 | 83 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 128.787 | 79 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 139.631 | 80 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 156.312 | 81 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 138.791 | 80 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 123.012 | 78 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 167.211 | 82 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 126.143 | 78 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 147.718 | 80 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 115.83 | 77 |